SCHEMBL29557693

SCHEMBL29557693

CC(=O)N1c2ccc(N(C)C)cc2Sc2cc(N(C)C)ccc21

nearest known ligand 0.67

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 3/20 0.67
TDP1 Q9NUW8 2/20 0.67
MEN1 O00255 1/20 0.67
KMT2A Q03164 1/20 0.67
L3MBTL1 Q9Y468 1/20 0.67
NOX1 Q9Y5S8 1/20 0.54
SNCA P37840 4/20 0.50
BCHE P06276 7/20 0.47
LMNA P02545 1/20 0.41
POLB P06746 1/20 0.40
ATM Q13315 1/20 0.40
P2RX4 Q99571 1/20 0.38
ALDH1A1 P00352 2/20 0.38
MAPT P10636 2/20 0.38
HTT P42858 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1208061 1.00 MAPK1 (0.67) MAPK1TDP1MEN1KMT2AL3MBTL1
SCHEMBL1926806 0.93 NOX1 (0.69) MAPK1TDP1MEN1KMT2AL3MBTL1
SCHEMBL8224985 0.93 MAPK1 (0.59) MAPK1TDP1MEN1KMT2AL3MBTL1
SCHEMBL21752063 0.93 SNCA (0.60) MAPK1TDP1MEN1KMT2AL3MBTL1
SCHEMBL20737960 0.90 MAPK1 (0.56) MAPK1TDP1MEN1KMT2AL3MBTL1
SCHEMBL11595006 0.90 MAPK1 (0.56) MAPK1TDP1MEN1KMT2AL3MBTL1
SCHEMBL21752026 0.89 SNCA (0.69) MAPK1TDP1MEN1KMT2AL3MBTL1
SCHEMBL18408661 0.89 MAPK1 (0.55) MAPK1TDP1MEN1KMT2AL3MBTL1
SCHEMBL18408657 0.88 MAPK1 (0.54) MAPK1TDP1MEN1KMT2AL3MBTL1
SCHEMBL10827710 0.88 MAPK1 (0.54) MAPK1TDP1MEN1KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119823064-A Preparation method of methylene blue 仁合益康集团有限公司 2025-04-15 CN claimed
CN-119823064-B Preparation method of methylene blue 仁合益康集团有限公司 2025-12-30 CN disclosed
EP-3795565-B1 IMPROVED PROCESS FOR THE PURIFICATION OF METHYLENE BLUE RK PHARMA INC (US) 2025-07-09 EP disclosed
CN-119823064-A Preparation method of methylene blue 仁合益康集团有限公司 2025-04-15 CN disclosed
CN-119823064-A Preparation method of methylene blue 仁合益康集团有限公司 2025-04-15 CN disclosed
US-20250000871-A1 PHENOTHIAZINE DIAMINIUM SALTS AND THEIR USE WISTA LABORATORIES LTD. (SG) 2025-01-02 US disclosed
US-12064439-B2 Phenothiazine diaminium salts and their use WISTA LABORATORIES LTD. (SG) 2024-08-20 US disclosed
CN-109384741-B 3,7-diamino-10H-phenothiazine compound salt and application thereof 维斯塔实验室有限公司 2023-01-06 CN disclosed
CN-104606199-B 3, 7-diamino-10H-phenothiazine compound salt and use thereof 维斯塔实验室有限公司 2022-09-13 CN disclosed
US-20220098161-A1 PHENOTHIAZINE DIAMINIUM SALTS AND THEIR USE WISTA LABORATORIES LTD. (SG) 2022-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12064439-B2 Phenothiazine diaminium salts and their use QDPR, SLC35A1, SLC6A7 MAPK1 2095/4885TDP1 1321/4885MEN1 655/4885
US-20220098161-A1 PHENOTHIAZINE DIAMINIUM SALTS AND THEIR USE QDPR, SLC35A1, SLC6A7 MAPK1 2095/4885TDP1 1321/4885MEN1 655/4885
US-20250000871-A1 PHENOTHIAZINE DIAMINIUM SALTS AND THEIR USE QDPR, SLC35A1, SLC6A7 MAPK1 2095/4885TDP1 1321/4885MEN1 655/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.